Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Medtronic PLC    MDT   IE00BTN1Y115

MEDTRONIC PLC (MDT)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Medtronic : NPPA SENDS MIXED SIGNALS WITH NOD FOR ABBOTT STENT WITHDRAWAL

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/28/2017 | 02:00am CET

The National Pharmaceutical Pricing Authority (NPPA) has allowed Abbott Healthcare to discontinue its drug-eluting stent, Alpine, from the Indian market - a decision that is sending mixed signals to the market. The NPPA has already permitted Abbott to withdraw its dissolvable stent, Absorb, from the market. NPPA's move has raised concerns over a 'sudden shortage' of cardiac stents in the market. NPPA has brought cardiac stents under price control and reduced the price of a drug-coated stent to Rs30,000 from Rs1.5- 1.9 lakh earlier. However, companies like Abbott and Medtronic have decided to withdraw some of their top drug-eluting stents from the Indian market as their margins would get hit.

Copyright (c) 2017 . Informatics India Ltd., source Indian Business Insight

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDTRONIC PLC
04:52a BOSTON SCIENTIFIC : Vercise is designed to more precisely target deep-brain stim..
12/14 MEDTRONIC : agrees to settlement with five states in Infuse case
12/12 MEDTRONIC : Announces Cash Dividend for Third Quarter of Fiscal Year 2018
12/12 65-- TITLE : Medtronic Situate Detection System X l Actionable Package 11/21/201..
12/12 MEDTRONIC PLC : Change in Directors or Principal Officers, Submission of Matters..
12/09 MEDTRONIC : Announces Cash Dividend for Third Quarter of FY 2018
12/08 MEDTRONIC : Announces Cash Dividend for Third Quarter of Fiscal Year 2018
12/07 MEDTRONIC : Intent to Sole Source - FA486118PB035
12/04 MEDTRONIC : Management's Discussion and Analysis of Financial Condition and Resu..
12/04 APPLE : Clinical trial puts Apple Watch's heart monitoring prowess to the test
More news
News from SeekingAlpha
12/14 The Next 20 Dividend Achievers Absolutely Trounce The Market
12/14 YOUR DAILY PHARMA SCOOP : Right Time To Buy Regeneron, Eli Lilly Gives Guidance,..
12/13 I'm Sticking With CVS And Walgreens, My Last Two Losers
12/12 Premarket analyst action - healthcare
12/11 BECTON DICKINSON : A Fully Valued Healthcare Blue Chip Stock
Financials ($)
Sales 2018 29 479 M
EBIT 2018 8 298 M
Net income 2018 5 343 M
Debt 2018 14 550 M
Yield 2018 2,21%
P/E ratio 2018 20,62
P/E ratio 2019 21,31
EV / Sales 2018 4,33x
EV / Sales 2019 4,10x
Capitalization 113 B
Chart MEDTRONIC PLC
Duration : Period :
Medtronic PLC Technical Analysis Chart | MDT | IE00BTN1Y115 | 4-Traders
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 90,2 $
Spread / Average Target 8,0%
EPS Revisions
Managers
NameTitle
Omar S. Ishrak Chairman & Chief Executive Officer
Mark Ploof Senior Vice President-Global Operations
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Richard H. Anderson Lead Independent Director
Craig Arnold Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MEDTRONIC PLC14.88%113 017
BAXTER INTERNATIONAL45.96%35 594
C R BARD INC47.78%24 382
ZIMMER BIOMET HOLDINGS INC10.00%23 333
HOYA CORPORATION12.50%18 958
ALIGN TECHNOLOGY145.12%18 726